SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups
2 other identifiers
interventional
100
1 country
1
Brief Summary
The purpose of this study is to test the feasibility and acceptability of Smokefree Sexual and Gender Minority (SGM), an SGM-tailored version of the SmokefreeTXT text messaging program
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2022
CompletedFirst Submitted
Initial submission to the registry
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 9, 2024
CompletedResults Posted
Study results publicly available
August 17, 2025
CompletedAugust 17, 2025
July 1, 2025
1.7 years
December 1, 2022
July 9, 2025
July 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Feasibility as Assessed by Number of Participants Recruited for the Study
Baseline
Feasibility as Assessed by Number of Participants That Completed Month 1 Visit
end of month 1
Feasibility as Assessed by Number of Participants That Completed Month 3 Visit
end of month 3
Feasibility as Assessed by Number of Participants That Completed Month 6 Visit
end of month 6
Acceptability as Assessed by Number of Participants Who Completed Qualitative Interviews
6 months follow up
Secondary Outcomes (3)
Number of Participants That Quit Smoking
1 month follow up
Number of Participants That Quit Smoking
3 month follow up
Number of Participants That Quit Smoking
6 month follow up
Study Arms (2)
SmokefreeSGM
EXPERIMENTALSmokefreeTXT
ACTIVE COMPARATORInterventions
Participants will be enrolled in a text-based smoking cessation program specifically designed to respond to the needs of LGBTQ+ smokers.
Participants will be enrolled in a text-based smoking cessation program specifically designed to respond to the needs of the general population
Eligibility Criteria
You may qualify if:
- Self-identify as an LGBTQ+ individual
- Currently live in the United States
- Have smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke greater than or equal to 5 cigarettes a day
- Are willing to quit smoking in the next 15 days
- Have a cell phone number with an unlimited short message service (SMS) plan
- Have a positive cotinine saliva test to indicate their smoking status
You may not qualify if:
- Have a prepaid cell phone plan (pay-as-you-go plan)
- Have a cell phone number that does not work and/or is registered to someone else
- Have inadequate equipment/devices (i.e., webcam, speakers, mic) for participating in telehealth sessions via Microsoft Teams, Webex, or Zoom AND cannot meet in-person
- Pregnant or breastfeeding persons (nicotine patches are not generally recommended to this groups since nicotine can affect fetal and neonatal brain development)
- Contraindication for nicotine patches. Absolute contraindications include: severe eczema or serious skin conditions, allergy to nicotine patches, pregnancy, breastfeeding, heart attack in the past 2 months, ongoing angina, peptic ulcer disease, arrhythmia, or uncontrolled blood pressure. Potential contraindications include: stroke in the past 6 months, insulin therapy, and a current diagnosis of liver, kidney, or heart disease. Study participants reporting a potential contraindication will require approval from their primary care provider and/or other treating physician (e.g., psychiatrist) to use nicotine patches. If the request is denied or not returned in 2 weeks, potential study participants will be excluded from the study.
- Current use of tobacco cessation medications
- Enrollment in another smoking cessation study
- Non-English speakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Related Publications (1)
Tundealao S, Oubda MC, Klaff R, Reininger B, McNeill L, Tami-Maury I. Pragmatic recruitment strategies for a text-based smoking cessation intervention for sexual and gender minority groups. Discov Public Health. 2025;22(1):743. doi: 10.1186/s12982-025-01117-0. Epub 2025 Nov 24.
PMID: 41306822DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Irene Tami-Maury, DMD,MSc,DrPH-NHSN
- Organization
- The University of Texas Health Science Center at Houston
Study Officials
- PRINCIPAL INVESTIGATOR
Irene Tami-Maury, DMD, DrPH, MSc
The University of Texas Health Science Center, Houston
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 1, 2022
First Posted
December 9, 2022
Study Start
November 10, 2022
Primary Completion
July 9, 2024
Study Completion
July 9, 2024
Last Updated
August 17, 2025
Results First Posted
August 17, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share